HomeMy WebLinkAboutMINUTES - 10202015 - C.47RECOMMENDATION(S):
Approve and authorize the Health Services Director, or his designee, to execute, on behalf of the County, Contract
Amendment Agreement #26-583-20 with Specialty Laboratories, Inc. (dba Quest Diagnostics Nichols Institute of
Valencia), a corporation, effective August 1, 2015, (to amend Contract #26-583-18) to increase the payment limit by
$600,000, from $950,000 to a new payment limit of $1,550,000, with no change in the original term of January 1,
2015 through December 31, 2015.
FISCAL IMPACT:
This amendment is funded 100% Hospital Enterprise Fund I. (No rate increase)
BACKGROUND:
On January 6, 2015, the Board of Supervisors approved Contract #26-583-18, with Specialty Laboratories, Inc. (dba
Quest Diagnostics Nichols Institute of Valencia) for the provision of outside specialized clinical laboratory services
at Contra Costa Regional Medical Center and Contra Costa Health Centers (CCRMC), for the period from January 1,
2015 through December 31, 2015. At the time of negotiations, the payment limit was based on target levels of
utilization. However,
APPROVE OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE
Action of Board On: 10/20/2015 APPROVED AS RECOMMENDED OTHER
Clerks Notes:
VOTE OF SUPERVISORS
AYE:John Gioia, District I Supervisor
Candace Andersen, District II
Supervisor
Mary N. Piepho, District III
Supervisor
Karen Mitchoff, District IV
Supervisor
Federal D. Glover, District V
Supervisor
Contact: Anna Roth,
925-370-5101
I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board
of Supervisors on the date shown.
ATTESTED: October 20, 2015
David Twa, County Administrator and Clerk of the Board of Supervisors
By: Chris Heck, Deputy
cc: K Cyr, N Rios
C. 47
To:Board of Supervisors
From:William Walker, M.D., Health Services Director
Date:October 20, 2015
Contra
Costa
County
Subject:Amendment #26-583-20 with Specialty Laboratories, Inc. (dba Quest Diagnostics Nichols Institute of Valencia)
BACKGROUND: (CONT'D)
the volume of specialized testing has been much higher than originally anticipated due to the increased use of a new
cancer screening test, the BRACA test. Approval of Contract Amendment Agreement #26-583-20 will allow the
Contractor to continue to provide additional outside clinical laboratory services at CCRMC through December 31,
2015.
CONSEQUENCE OF NEGATIVE ACTION:
If this amendment is not approved, the Contractor will not be paid for additional specialized testing services provided
to CCRMC patients during the contract period.
CHILDREN'S IMPACT STATEMENT:
Not applicable.